Showing results (1-10 of 108) with videos related to
Sort By:
Pageof 11
Expert Opinion on Drug Metabolism & Toxicology|November 20, 2012
Pharmacology of dimethanesulfonate alkylating agents: busulfan and treosulfanAriane Galaup, Angelo PaciCancer Letters|July 13, 2024
"Cyclophosphamide and analogues; a matter of dose and schedule for dual anticancer activities"Julia Delahousse, Leonardo Molina, Angelo PaciDrugs in R&D|July 17, 2015
Stability of Melphalan in 0.9% Sodium Chloride Solutions Prepared in Polyvinyl Chloride Bags for Intravenous InjectionRomain-Pacôme Desmaris, Lionel Mercier, Angelo PaciJournal of Pharmaceutical and Biomedical Analysis|July 19, 2005
Fluorescence detection combined with either HPLC or HPTLC for pharmaceutical quality control in a hospital chemotherapy production unit: application to camptothecin derivativesEdmond Gravel, Philippe Bourget, Lionel Mercier, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 8, 2006
Microbial growth tests in anti-neoplastic injectable solutionsIsabelle Paris, Angelo Paci, Jean-Baptiste Rey, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 26, 2006
Liquid chromatography-tandem mass spectrometry assay of reduced and oxidized glutathione and main precursors in mice liverJérôme Bouligand, Alain Deroussent, Angelo Paci, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2019
Antidrug Antibodies Against Immune Checkpoint Blockers: Impairment of Drug Efficacy or Indication of Immune Activation?Diego Enrico, Angelo Paci, Nathalie Chaput, et al.Journal of Hematology & Oncology|January 16, 2022
Immune checkpoint-targeted antibodies: a room for dose and schedule optimization?Christophe Maritaz, Sophie Broutin, Nathalie Chaput, et al.Expert Opinion on Drug Metabolism & Toxicology|March 20, 2023
Individualizing busulfan dose in specific populations and evaluating the risk of pharmacokinetic drug-drug interactionsDavid Combarel, Julie Tran, Julia Delahousse, et al.Bulletin Du Cancer|March 13, 2016
[Tyrosine kinase inhibitors and pregnancy: A risk to the fetus?]Cécile Jovelet, Sophie Broutin, Sophie Gil, et al.Pageof 11